JP Morgan Healthcare Conference kicks off
AZ's Epanova flunks key heart risk trial, giving Amarin's Vascepa a leg up
Charles River and Takeda pen early-stage drugs deal
Biogen pays Pfizer $75M for an early-stage Alzheimer's drug asset
*please scroll down for all the latest news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
